Hypothesis: Radiosensitization using Xeloda should improve the rate of complete pain relief. Primary Objective: * To determine the frequency of pain relief for the proposed regimen. Secondary Objective(s): * To determine the duration of pain relief and narcotic relief for the proposed regimen. * To determine the frequency of narcotic relief for the proposed regimen. * To determine the toxicity of concurrent UFT and radiotherapy in patients with bone metastases.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Rambam Health Care Campus
Haifa, Israel
RECRUITINGThe frequency of pain relief for the proposed regimen, using a scale that takes into account the subjective feeling and the use of analgesics
Time frame: after 3 months
The duration of pain relief and narcotic relief for the proposed regimen after one year
The frequency of narcotic relief for the proposed regimen after one year
The toxicity of concurrent UFT and radiotherapy in patients with bone metastases after one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.